Neuroinflammation and immune-brain interactions

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

183 papers

Active filtersClassification:Supporting

Showing 121-132 of total 183 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

The interplay between chronobiology, neuroinflammation, and the glymphatic system in neurodegenerative diseases.

Akar A; Erbil G; Aykora D; Uzun M

Jan 1, 2026

2026PubMedSupporting evidence

Targeting the Complement-Microglia Axis for Neuroprotection in Pediatric Epilepsy.

Karayanni M; Mitsoudis N; Vanakliotou M; Bakirtzis C; Kesidou E; Polyzoidou E; Liana E

Jan 1, 2026Biomedicines

2026PubMedSupporting evidence

Differential Effects of Cannabidiol and Cannabigerol on Cognition, Neuroinflammation, and Blood-Brain Barrier Integrity in a Rat Model of Iron Overload.

Kowalski L; Colucci ACM; Dos Santos JB; Vuaden BW; Herlinger AL; Hallak JEC; Zuardi AW; Crippa JAS; de Lima MNM; Schröder N

Jan 1, 2026Neurotoxicity research

2026PubMedSupporting evidence

Transcriptomic Signatures of Microglial Phagocytosis Reveal Diagnostic Markers and Immune Landscape in Alzheimer's Disease.

Chang H; Liu Y; Yang X; Han Y

Jan 1, 2026FASEB journal : official publication of the Federation of American Societies for Experimental Biology

2026PubMedSupporting evidence

The gut-immune-brain axis in CNS tumors: Causal roles of microbiota and inflammatory proteins unveiled by Mendelian randomization and single-cell transcriptomics.

Cao X; Guo H; Wang K; Wu Q; Wang X; Shao J

Jan 1, 2026Medicine

2026CrossrefSupporting evidence0 citations

Microglia statuses in Alzheimer’s disease and lessons from anti-tumor microglia

Julia Y. Cai; Yellamandayya Vadlamudi; Praveen Agrawal

Jan 1, 2026Geromedicine

2026PubMedSupporting evidence

Bridging the gap: neuroinflammation and the dawn of precision medicine in amyotrophic lateral sclerosis.

Tang L; Fan D

Jan 1, 2026Translational neurodegeneration

2026PubMedSupporting evidence

The gut microbiota-immune-brain axis in post-traumatic stress disorder: mechanistic integration and translational prospects.

Zheng X; Li D; Yao X; Luo X; Gao C; Yan X

Jan 1, 2026Frontiers in immunology

2026PubMedSupporting evidence

Icariside II in Neurological Disorders: Mechanistic Insights Into Alzheimer's Disease, Cerebral Ischemia and Parkinson's Disease.

Solanki A; Sharma K; Jain J; Singh NK; Krishnamurthy PT

Jan 1, 2026Journal of biochemical and molecular toxicology

2026PubMedSupporting evidence

Icariside II in Neurological Disorders: Mechanistic Insights Into Alzheimer's Disease, Cerebral Ischemia and Parkinson's Disease.

Solanki A; Sharma K; Jain J; Singh NK; Krishnamurthy PT

Jan 1, 2026Journal of biochemical and molecular toxicology

2024CrossrefSupporting evidence1 citations

AD genes and microglia phenotypes: does microglia phenotypic heterogeneity matter?

Marta Olah

Dec 1, 2024Alzheimer's & Dementia

2024CrossrefSupporting evidence5 citations

Clinical Aspects and Significance of β-Chemokines, γ-Chemokines, and δ-Chemokines in Molecular Cancer Processes in Acute Myeloid Leukemia (AML) and Myelodysplastic Neoplasms (MDS)

Jan Korbecki; Mateusz Bosiacki; Piotr Stasiak; Emilian Snarski; Agnieszka Brodowska; Dariusz Chlubek; Irena Baranowska-Bosiacka

Sep 24, 2024Cancers